首页> 外文期刊>Cahiers de nutrition et de dietetique >Genes and intestinal absorption of lipidic microconstituents (fat-soluble vitamins, carotenoids and phytosterols) [Gènes et absorption intestinale des microconstituants lipidiques (vitamines liposolubles, caroténo?des et phytostérols)]
【24h】

Genes and intestinal absorption of lipidic microconstituents (fat-soluble vitamins, carotenoids and phytosterols) [Gènes et absorption intestinale des microconstituants lipidiques (vitamines liposolubles, caroténo?des et phytostérols)]

机译:脂质微成分(脂溶性维生素,类胡萝卜素和植物甾醇)的基因和肠道吸收[脂溶性维生素(脂溶性维生素,类胡萝卜素和植物甾醇)的基因和肠道吸收]

获取原文
获取原文并翻译 | 示例
       

摘要

Intestinal absorption of lipidic microconstituents (LM) is very variable and depends on numerous factors. Recent studies have shown that, contrary to what was assumed, proteins are involved in absorption of LM by enterocyte. It is likely that genetic polymorphisms in genes encoding for these proteins modulate absorption efficiency of these compounds. This hypothesis can explain the huge interindividual variability in absorption efficiency of these compounds. The effect of genetic variants on absorption efficiency of LM may in turn lead to modify plasma and tissues concentration of LM and, finally, their ability to prevent some diseases (cardiovascular diseases, cancers..). Recent results support these hypothesis. However, other studies are required to definitely conclude on the real effect of genetic variants of intestinal transporters of LM on status and health effect of these compounds. Since most LM seems beneficial for health at low (dietary) doses and can be hazardous at higher (pharmacological) doses, it can be anticipated that recommended dietary allowances of LM, or doses of LM in functional foods/supplements, will be adapted to groups of the population carrying common genetic variants known to significantly affect LM bioavailability.
机译:脂质微成分(LM)在肠道的吸收变化很大,并取决于许多因素。最近的研究表明,与假设相反,蛋白质参与肠细胞对LM的吸收。编码这些蛋白质的基因中的遗传多态性可能会调节这些化合物的吸收效率。该假设可以解释这些化合物吸收效率的巨大个体差异。遗传变异对LM吸收效率的影响反过来可能会改变LM的血浆和组织浓度,并最终改变其预防某些疾病(心血管疾病,癌症等)的能力。最近的结果支持了这些假设。但是,还需要其他研究来明确总结LM肠转运蛋白的遗传变异对这些化合物的状态和健康影响的实际作用。由于大多数LM似乎在低(饮食)剂量下对健康有益,而在更高(药理)剂量下可能有害,因此可以预期,建议的LM饮食允许量或功能性食品/补充食品中的LM剂量将适合人群携带已知会显着影响LM生物利用度的常见遗传变异的人群中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号